Our Chief Technologist considers the challenges faced by biopharmaceutical manufacturers, and discusses the new compact mass spectrometry technologies available to characterise proteins and enhance process controls.
Read the full article here, or download here.
This article is taken from Innovations in Pharmaceutical Technology July 2019, pages 31-33. © Samedan Ltd
Share This Story, Choose Your Platform!
Newsletter signup
"*" indicates required fields